首页> 外文期刊>Advances in Rheumatology >Comments on “Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of Chikungunya fever. Part 2 - Treatment”
【24h】

Comments on “Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of Chikungunya fever. Part 2 - Treatment”

机译:评论“巴西风湿病学会对基孔肯雅热的诊断和治疗建议。第2部分-治疗”

获取原文
           

摘要

Our study was reported according to the CONSORT guidelines. The sample size calculation was performed to provide 80% power at 5% significance level assuming a dropout rate of 10% and estimated 35 patients per group. In our study all patients in the DMARDs group received SSZ at fixed dose. None of the patients in either group received SSZ as monotherapy or MTX as an add-on to SSZ therapy.
机译:根据CONSORT指南报告了我们的研究。假设辍学率为10%,并进行了样本量计算,以5%的显着性水平提供80%的功效,并且每组估计有35名患者。在我们的研究中,DMARDs组的所有患者均接受固定剂量的SSZ。两组患者均未接受SSZ单一疗法或MTX作为SSZ疗法的附加药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号